MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KASLOW, H. R.
Right arrow Articles by BOURNE, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KASLOW, H. R.
Right arrow Articles by BOURNE, H. R.

Molecular Pharmacology, Vol 15, 472-483, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

Adenylate Cyclase Assembled In Vitro: Cholera Toxin Substrates Determine Different Patterns of Regulation by Isoproterenol and Guanosine 5'-triphosphate

HARVEY R. KASLOW 1, ZVI FARFEL 1, GARY L. JOHNSON 1, and HENRY R. BOURNE 1

1 Division of Clinical Pharmacology, Departments of Medicine and Pharmacology and the Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California 94143

Genetic and biochemical evidence indicates that hormone-sensitive adenylate cyclase consists of at least three separable components: hormone receptor (R), a catalytic unit (C) that synthesizes cAMP from ATP, and one or more regulatory factors, which we have termed N, that are required for functional coupling of R and C and also for cyclase stimulation by guanyl nucleotides, NaF, and cholera toxin. The functional absence of N in a S49 lymphoma variant clone, cyc-, allows in vitro assembly of hormone-sensitive adenylate cyclase, using cyc- membranes and N components in detergent extracts from membranes of other cells (Ross, E. M. and Gilman, A. G. Proc. Nat. Acad. Sci., USA 74,3715-3719, 1977). Such cyclase systems, assembled in vitro using N components from wild type S49 cells and turkey erythrocytes, are functionally distinguishable, each resembling—in responses to guanyl nucleotides and isoproterenol—the cyclase system from which the N component was derived. Thus, the N component determines certain functional characteristics of the response to guanine nucleotides and isoproterenol. Human erythrocyte membranes, which are virtually devoid of catalytic adenylate cyclase, also contain the functional N component. Donor extracts of human and turkey erythrocytes and S49 cells contain cholera toxin substrates, by two criteria: 1. The extracts transmit effects of toxin on donor membranes to adenylate cyclase assembled in vitro using cyc- membranes; 2. Incubation with toxin plus [32P]NAD+ specifically radiolabels substrates in each type of membrane, including a peptide of Mr = 42,000, common to all three. The results are consistent with the hypothesis that this peptide participates directly in multiple functions of N.

Note:
ACKNOWLEDGMENT We thank Ms. Mary Gleason for expert technical assistance.

Submitted on October 2, 1978
Accepted on December 6, 1978




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Gille, H.-Y. Liu, S. R. Sprang, and R. Seifert
Distinct Interactions of GTP, UTP, and CTP with Gs Proteins
J. Biol. Chem., September 6, 2002; 277(37): 34434 - 34442.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
S. Steinberg, E. Drugge, J. Bilezikian, and R. Robinson
Acquisition by innervated cardiac myocytes of a pertussis toxin-specific regulatory protein linked to the alpha 1-receptor
Science, October 11, 1985; 230(4722): 186 - 188.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics